LMAT, US5255582018

Analysts set USD 110.60 target for LeMaitre Vascular stock

Published on 10/20/2026 at 18:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Nine analysts give LeMaitre a Hold consensus and USD 110.60 target. LeMaitre Vascular stock costs EUR 74.00 on October 20, 2026 at 6:29 p.m. CEST.

Hold consensus among nine firms

Nine research firms held a Hold consensus and an average 12-month target of USD 110.60 on October 15, 2026.
Second-quarter 2026 revenue reached USD 70.38 million, up 9.60 percent year over year, while earnings per share were USD 0.74.
LeMaitre Vascular stock costs EUR 74.00 at Lang & Schwarz on October 20, 2026 at 6:29 p.m. CEST.
LeMaitre Vascular will release third-quarter 2026 results on November 4, 2026.

LMAT, US5255582018, Illustration mit AI erstellt.

LeMaitre Vascular (ISIN US5255582018) carries a Hold consensus from nine research firms and an average 12-month target of USD 110.60, according to MarketBeat on October 15, 2026. That target stands 32.99 percent above the USD 83.17 Nasdaq price on October 20, 2026, using the same currency. After the Xetra close, LeMaitre Vascular was trading at EUR 74.00 at Lang & Schwarz on October 20, 2026 at 6:29 p.m. CEST.

Second-quarter sales rose 9.60 percent

LeMaitre's second-quarter 2026 revenue reached USD 70.38 million, up 9.60 percent from the same quarter a year earlier. The company earned USD 17.05 million, or USD 0.74 in diluted earnings per share, according to LeMaitre Vascular and MarketBeat. Revenue was USD 1.09 million below the USD 71.47 million consensus, while earnings per share missed the USD 0.81 estimate by USD 0.07.

Stock sits above its yearly low

The Nasdaq-listed medical device company had a 52-week range of USD 78.22 to USD 118.01 on October 20, 2026. At USD 83.17, the stock was 6.33 percent above its yearly low and 29.52 percent below its yearly high. Trading volume stood at 42,302 shares, while the market capitalization was USD 1.9 billion and the price-to-earnings ratio was 29.17.

USD 1.9 billion value and November 4 date

LeMaitre declared a quarterly dividend of USD 0.25 per share in its second-quarter update, equivalent to a 1.20 percent yield, according to MarketBeat. The company said on October 12, 2026 that it will release third-quarter 2026 results after the market close on November 4, 2026, with a conference call at 5:00 p.m. ET, according to LeMaitre Vascular.

Target distance frames the valuation

The USD 110.60 consensus target is 32.99 percent above the USD 83.17 Nasdaq price, while the Hold view shows that the target does not represent a uniform analyst stance. For the next scheduled catalyst, the November 4 results will provide the next reported comparison for revenue, earnings and guidance.